Helene Pere

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

Drug interaction between maribavir and rifampin: a case report.

Drug interaction between maribavir and rifampin: a case report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 28, 2026

HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinoma.

HPV16 genomic status stratifies risk of disease recurrence in oropharyngeal squamous cell carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 18, 2026

HPV-related oropharyngeal cancers: main characteristics and new virological tools

HPV-related oropharyngeal cancers: main characteristics and new virological tools

Journal: Virologie (Montrouge, France)

Published: March 06, 2026

Advances in screening and follow-up of HPV-related cervical cancer

Advances in screening and follow-up of HPV-related cervical cancer

Journal: Virologie (Montrouge, France)

Published: March 06, 2026

A look back at the 17th Scientific Conference of the Association francophone pour l'étude des infections par les papillomavirus et les polyomavirus (Afipp)

A look back at the 17th Scientific Conference of the Association francophone pour l'étude des infections par les papillomavirus et les polyomavirus (Afipp)

Journal: Virologie (Montrouge, France)

Published: March 06, 2026

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 22, 2026

Clonal origin and early lineage divergence in adenosquamous carcinoma.

Clonal origin and early lineage divergence in adenosquamous carcinoma.

Journal: Cell reports

Published: January 20, 2026

Risk factors for acquisition of SARS-CoV-2 Omicron variant among a prospective cohort of French Healthcare Workers: impact of hybrid immunity.

Risk factors for acquisition of SARS-CoV-2 Omicron variant among a prospective cohort of French Healthcare Workers: impact of hybrid immunity.

Journal: Scientific reports

Published: January 05, 2026

Intensification or de-escalation? What is the standard treatment for human papillomavirus-related oropharyngeal cancers in 2025?

Intensification or de-escalation? What is the standard treatment for human papillomavirus-related oropharyngeal cancers in 2025?

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: May 16, 2025

HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association.

HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association.

Journal: Journal of medical virology

Published: May 15, 2025

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.

Journal: Nature communications

Published: April 22, 2025

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms.

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms.

Journal: RMD open

Published: March 14, 2025

Showing 1-12 of 127

Last Updated: 09/26/2026